Anti-vascular endothelial growth factor (anti-VEGF) therapies are effective and well-tolerated medications that have revolutionized the treatment of retinal conditions such as neo-vascular age-related macular degeneration and macular oedema in diabetic retinopathy or retinal vein occlusions10. The gene discussed is VEGFA; the disease is macular retinal edema.